Skip Navigation LinksHome > Search Results



Docket for 20-779
RSS Feed Print Notify Me
Search documents in this case:
No. 20-779
Title:Argentum Pharmaceuticals LLC, Petitioner
v.
Novartis Pharmaceuticals Corporation
Docketed:December 8, 2020
Lower Ct:United States Court of Appeals for the Federal Circuit
   Case Numbers:(2018-2273)
   Decision Date:April 23, 2020
   Rehearing Denied:July 9, 2020
  Discretionary Court Decision Date:

DateProceedings and Orders
Dec 04 2020Petition for a writ of certiorari filed. (Response due January 7, 2021)
PetitionCertificate of Word CountProof of Service
Dec 22 2020Waiver of right of respondent Novartis Pharmaceuticals Corporation to respond filed.
Main Document
Jan 06 2021DISTRIBUTED for Conference of 1/22/2021.
Jan 07 2021Brief amicus curiae of Jonathan Stroud filed. (Distributed)
Main DocumentProof of ServiceCertificate of Word Count
Jan 14 2021Response Requested. (Due February 16, 2021)
Feb 16 2021Brief of respondent Novartis Pharmaceuticals Corporation in opposition filed.
Main DocumentOtherCertificate of Word CountProof of Service
Mar 03 2021DISTRIBUTED for Conference of 3/19/2021.
Mar 03 2021Reply of petitioner Argentum Pharmaceuticals LLC filed. (Distributed)
Main DocumentCertificate of Word CountProof of Service
Mar 22 2021Petition DENIED.

NAMEADDRESSPHONE
Attorneys for Petitioner
Teresa Stanek Rea
    Counsel of Record
Crowell & Moring LLP
1001 Pennsylvania Ave., N.W.
Washington, DC 20004-2595

trea@crowell.com
2026242620
Party name: Argentum Pharmaceuticals LLC
Attorneys for Respondent
Mark Andrew Perry
    Counsel of Record
Gibson Dunn & Crutcher, LLP
1050 Connecticut Avenue, NW
Washington, DC 20036

mperry@gibsondunn.com
202-887-3667
Party name: Novartis Pharmaceuticals Corporation
Other
Jonathan Rudolph Kominek Stroud
    Counsel of Record
Unified Patents, LLC
1875 Connecticut Ave., NW Floor 10
Washington, DC 20009

jonathan@unifiedpatents.com
202-805-8931
Party name: Jonathan Stroud

 

SUPREME COURT OF THE UNITED STATES 1 First Street, NE Washington, DC 20543